Kyorin Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2015; Provides Earnings Forecast for the Six Months and Full Year of Fiscal 2016; Announces Dividend for the Year End of Fiscal Year 2015, Payable on June 9, 2015; Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year 2016
May 12, 2015
Share
KYORIN Holdings, Inc. announced consolidated earnings results for the full year ended March 31, 2015. For the year, the company reported net sales of JPY 113,121 million compared with JPY 111,400 million for the same period a year ago. Operating income was JPY 14,737 million compared with JPY 17,607 million for the same period a year ago. Ordinary income was JPY 15,490 million compared with JPY 18,281 million for the same period a year ago. Net income was JPY 12,064 million or JPY 161.63 per share compared with JPY 12,025 million or JPY 160.95 per share for the same period a year ago. Return on equity was 8.4% compared with 9.0% for the same period a year ago. Cash flows from operating activities was JPY 6,391 million compared with JPY 19,293 million for the same period a year ago.
The company provided earnings guidance for the first half of fiscal 2016 and for the full year ending March 31, 2016. For the first half, the company expects to report net sales of JPY 54,400 million, operating income of JPY 3,800 million, ordinary income of JPY 4,000 million and net income of JPY 2,600 million or JPY 35.16 per share.
For the full year ending March 31, 2016, the company expects to report net sales of JPY 120,200 million, operating income of JPY 16,000 million, ordinary income of JPY 16,300 million and net income of JPY 11,500 million or JPY 155.51 per share.
The company announced a year end dividend of JPY 32.00 per share, payable on June 9, 2015.
The company provided dividend guidance for the second quarter and for the fiscal year ending March 31, 2016. For the second quarter, the company plans to pay a dividend of JPY 20.00 per share and a final dividend of JPY 32.00 per share.
Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
Kyorin Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2015; Provides Earnings Forecast for the Six Months and Full Year of Fiscal 2016; Announces Dividend for the Year End of Fiscal Year 2015, Payable on June 9, 2015; Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year 2016